epz-6438 and Osteosarcoma

epz-6438 has been researched along with Osteosarcoma* in 1 studies

Other Studies

1 other study(ies) available for epz-6438 and Osteosarcoma

Article	Year
Surface expression of the immunotherapeutic target G Cancer reports (Hoboken, N.J.), 2021, Volume: 4, Issue:5 Chimeric antigen receptor (CAR) T-cell therapy of pediatric sarcomas is challenged by the paucity of targetable cell surface antigens. A candidate target in osteosarcoma (OS) is the ganglioside G. We aimed to identify mechanisms that upregulate G. G. Expression of G Topics: Benzamides; Biphenyl Compounds; Bone Neoplasms; Brefeldin A; Cell Culture Techniques; Cytotoxicity, Immunologic; Enhancer of Zeste Homolog 2 Protein; Gangliosides; Humans; Morpholines; Osteosarcoma; Protein Synthesis Inhibitors; Pyridones; Surface Properties; T-Lymphocytes; Tumor Cells, Cultured	2021

Article

Year

Surface expression of the immunotherapeutic target G

Cancer reports (Hoboken, N.J.), 2021, Volume: 4, Issue:5

Chimeric antigen receptor (CAR) T-cell therapy of pediatric sarcomas is challenged by the paucity of targetable cell surface antigens. A candidate target in osteosarcoma (OS) is the ganglioside G. We aimed to identify mechanisms that upregulate G. G. Expression of G

Topics: Benzamides; Biphenyl Compounds; Bone Neoplasms; Brefeldin A; Cell Culture Techniques; Cytotoxicity, Immunologic; Enhancer of Zeste Homolog 2 Protein; Gangliosides; Humans; Morpholines; Osteosarcoma; Protein Synthesis Inhibitors; Pyridones; Surface Properties; T-Lymphocytes; Tumor Cells, Cultured

2021